Related references
Note: Only part of the references are listed.High Alloreactivity of Low-Dose Prophylactic Donor Lymphocyte Infusion in Patients with Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation with an Alemtuzumab-Containing Conditioning Regimen
Maria Liga et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma
Monica Casucci et al.
BLOOD (2013)
Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
M. Stern et al.
BONE MARROW TRANSPLANTATION (2013)
Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies
Michal J. Besser et al.
CLINICAL CANCER RESEARCH (2013)
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
Aurelien Marabelle et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
Philippe Armand et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1
R. Oostvogels et al.
LEUKEMIA (2013)
Antigen-specific T-cell activation independently of the MHC: chimeric antigen receptor-redirected T cells
Markus Chmielewski et al.
FRONTIERS IN IMMUNOLOGY (2013)
Arming NK cells with enhanced antitumor activity CARs and beyond
Pranav Oberoi et al.
ONCOIMMUNOLOGY (2013)
The role of natural killer cells in hematopoietic stem cell transplantation
Panagiotis D. Tsirigotis et al.
ANNALS OF MEDICINE (2012)
Graft-versus-Host Disease Induced Graft-versus-Leukemia Effect: Greater Impact on Relapse and Disease-Free Survival after Reduced Intensity Conditioning
Daniel Weisdorf et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Mobilized Peripheral Blood Stem Cells Compared with Bone Marrow as the Stem Cell Source for Unrelated Donor Allogeneic Transplantation with Reduced-Intensity Conditioning in Patients with Acute Myeloid Leukemia in Complete Remission: An Analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Arnon Nagler et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
CARs and cancers: questions and answers
Renier J. Brentjens
BLOOD (2012)
Coinhibitory molecules in hematologic malignancies: targets for therapeutic intervention
Wieger J. Norde et al.
BLOOD (2012)
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
Norbert Vey et al.
BLOOD (2012)
A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma
Don M. Benson et al.
BLOOD (2012)
Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL
Max S. Topp et al.
BLOOD (2012)
Programmed Death Ligand 2 in Cancer-Induced Immune Suppression
Esdy N. Rozali et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Identification of 4 novel HLA-B*40:01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivity
Marieke Griffioen et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Bispecific and Trispecific Killer Cell Engagers Directly Activate Human NK Cells through CD16 Signaling and Induce Cytotoxicity and Cytokine Production
Michelle K. Gleason et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
How do CARs work? Early insights from recent clinical studies targeting CD19
Marco L. Davila et al.
ONCOIMMUNOLOGY (2012)
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
Antonio Curti et al.
BLOOD (2011)
Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma
Evan J. Lipson et al.
CLINICAL CANCER RESEARCH (2011)
Optimization of the HA-1-specific T-cell receptor for gene therapy of hematologic malignancies
Marleen M. van Loenen et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia
Marie Bleakley et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
Paul F. Robbins et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Antonio Di Stasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
MAGE-A family: Attractive targets for cancer immunotherapy
Meixiang Sang et al.
VACCINE (2011)
On the Composition of the Preimmune Repertoire of T Cells Specific for Peptide-Major Histocompatibility Complex Ligands
Marc K. Jenkins et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Functional characterization of alloreactive T cells identifies CD25 and CD71 as optimal targets for a clinically applicable allodepletion strategy
Sujith Samarasinghe et al.
BLOOD (2010)
Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens
Edus H. Warren et al.
BLOOD (2010)
Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I study
Shimon Slavin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
Michael A. Curran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation
Asad Bashey et al.
BLOOD (2009)
A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS
Ulrich Keilholz et al.
BLOOD (2009)
Selective depletion of alloreactive T cells by targeted therapy of heat shock protein 90: a novel strategy for control of graft-versus-host disease
Claudia Stuehler et al.
BLOOD (2009)
Bispecific T-Cell Engaging Antibodies for Cancer Therapy
Patrick A. Baeuerle et al.
CANCER RESEARCH (2009)
Minimally Cultured or Selected Autologous Tumor-infiltrating Lymphocytes After a Lympho-depleting Chemotherapy Regimen in Metastatic Melanoma Patients
Michal J. Besser et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study
Fabio Ciceri et al.
LANCET ONCOLOGY (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Characterizing and optimizing immune responses to leukaemia antigens after allogeneic stem cell transplantation
Katayoun Rezvani et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2008)
A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique
Stephan Mielke et al.
BLOOD (2008)
A pilot study of prophylactic donor lymphocyte infusions to prevent relapse in adult acute lymphoblastic leukemias after allogeneic hematopoietic stem cell transplantation
C. Lutz et al.
BONE MARROW TRANSPLANTATION (2008)
Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia - Feasibility and safety study
Xiao-Jun Huang et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2008)
Tumor regression in cancer patients by very low doses of a T cell-engaging antibody
Ralf Bargou et al.
SCIENCE (2008)
RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses
Michael Schmitt et al.
BLOOD (2008)
Donor lymphocyte infusion in the treatment of first Hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia:: A retrospective risk factors analysis and comparison with other strategies by the EBMT acute leukemia working party
Christoph Schmid et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation
Fabio Ciceri et al.
BLOOD (2007)
Allorecognition and the alloresponse: clinical implications
B. Afzali et al.
TISSUE ANTIGENS (2007)
The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies
Catia Traversari et al.
BLOOD (2007)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma
N. W. C. J. van de Donk et al.
BONE MARROW TRANSPLANTATION (2006)
T cells targeted against a single minor histocompatibility antigen can cure solid tumors
MC Meunier et al.
NATURE MEDICINE (2005)
Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study
SJ Choi et al.
BONE MARROW TRANSPLANTATION (2005)
Selective depletion strategies in allogeneic stem cell transplantation
S Mielke et al.
CYTOTHERAPY (2005)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
Minor histocompatibility antigens as targets of cellular immunotherapy in leukaemia
JHF Falkenburg et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2004)
Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation
JR Passweg et al.
LEUKEMIA (2004)
IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation
U Koehl et al.
BLOOD CELLS MOLECULES AND DISEASES (2004)
Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse
SJ Choi et al.
LEUKEMIA (2004)
Syngeneic hematopoietic stem-cell transplantation for Non-Hodgkin's lymphoma: A comparison with allogeneic and autologous transplantation - The lymphoma working committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation
PJ Bierman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Safety of retroviral gene marking with a truncated NGF receptor
C Bonini et al.
NATURE MEDICINE (2003)
Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose
C Guglielmi et al.
BLOOD (2002)
Treatment of leukemia by alloreactive lymphocytes and nonmyeloablative stem cell transplantation
S Slavin et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2002)
Randomized trial of CD8(+) T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion
RJ Soiffer et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Cutting edge:: Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells
CA Piccirillo et al.
JOURNAL OF IMMUNOLOGY (2001)
Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease
P Fontaine et al.
NATURE MEDICINE (2001)
Long-term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation
A Shimoni et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)
Donor leukocyte infusions in acute lymphocytic leukemia
RH Collins et al.
BONE MARROW TRANSPLANTATION (2000)
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
JJ Molldrem et al.
NATURE MEDICINE (2000)
Share Paper
